A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma

NCT05324501 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic decision

Conditions

Recurrent Glioblastoma

Interventions

DRUG: MTX110
DEVICE: Programmable pump and catheter system

Sponsor

Biodexa Pharmaceuticals